Performing Laparoscopic Surgery for Colorectal and Gastric Cancer Outside the Primary Registered Medical Institution

Safety and Feasibility of Performing Laparoscopic Surgery for Colorectal and Gastric Cancer Outside the Primary Registered Medical Institution Under Multi-sites Practice (MSP) Policy, a Retrospective Comparative Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04834661

Enrollment

1130

Registered

2021-04-08

Start date

2021-10-20

Completion date

2021-12-31

Last updated

2022-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer, Gastric Cancer

Brief summary

This study investigates the safety and feasibility of performing laparoscopic surgery for colorectal and gastric cancer inside versus outside the primary registered medical institution under multi-sites practice (MSP) policy. This is a single practitioner, retrospective comparative study. The endpoints are peri-operative outcomes, pathological results, and medical costs.

Interventions

OTHERsurgery inside the primary institution

to perform laparoscopic surgery for colorectal and gastric cancer inside the primary registered medical institution

OTHERsurgery outside the primary institution

to perform laparoscopic surgery for colorectal and gastric cancer outside the primary registered medical institution

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 100 Years

Healthy volunteers

Inclusion criteria

* Age between 18 and 100 years * diagnosed as colorectal cancer or gastric cancer * undergoing laparoscopic surgery between 2016-2020 performed by Dr Feng

Exclusion criteria

* Emergency procedure * without histopathological result of malignancy * conventional open surgery

Design outcomes

Primary

Measure	Time frame	Description
overall postoperative complication rate	30 days after surgery	postoperative complications evaluated according to Clavin-Dindo classification

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026